Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Almac announces clinical trial for ovarian cancer developing ALM201 for initial indication
Monday, March 09, 2015Almac Discovery has announced that it is to start its first clinical trial for ovarian cancer The announcement which coincides with the start of Ovarian Cancer Month involves the use of a proprietary novel therapeutic drug ALM which is being develop...
Swiss group Novartis leads productivity, bringing down pharma costs
Monday, March 09, 2015Swiss group pushes through sweeping reorganisation aimed at boosting growth Novartis is showing the way for big pharmaceutical groups to become more productive according to its chief executive as the Swiss group pushes through a sweeping reorganisat...
TransTech Pharma's new licensing deal could be worth $100M
Saturday, March 07, 2015A new licensing agreement recently inked by TransTech Pharma for one of its cancer treatment programs could mean an infusion of more than million for the High Point pharmaceutical firm TransTech Pharma and High Point Pharmaceuticals the sister comp...
ANI Pharmaceuticals acquires Generic Drug Product from Teva Pharmaceuticals
Friday, March 06, 2015ANI Pharmaceuticals Inc announced that it has acquired the approved abbreviated new drug application ANDA for Flecainide Acetate tablets USP mg mg and mg previously marketed by Teva Pharmaceuticals According to IMS Health the overall market for this...
Arrowhead acquires Novartis’ RNAi Research and Development Portfolio
Friday, March 06, 2015Arrowhead Research Corp was trading higher on Thursday after the announcement that it acquired Novartis entire RNAi research and development portfolio According to Street Insider Novartis has been working in the RNAi field for over a decade and thei...
AbbVie to buy Pharmacyclics for $21 billion to boost cancer drugs pipeline
Thursday, March 05, 2015Drugmaker AbbVie Inc said it will buy Pharmacyclics Inc the maker of blockbuster cancer drug Imbruvica for about billion to broaden its oncology drugs pipeline The deal gives AbbVie access to Pharmacyclics cancer drugs portfolio lessening the Chica...
Baxter's BioScience Business acquires Biopharmaceutical Company SuppreMol for EUR 200 million
Thursday, March 05, 2015Baxter International Inc and SuppreMol GmbH today announced that Baxter has acquired SuppreMol for EUR million approximately M USD before working capital and other adjustments SuppreMol is a privately held biopharmaceutical company based in Martinsr...
Ranbaxy loses approvals, exclusivity of two drugs in US
Wednesday, March 04, 2015Ranbaxy Laboratories tentative approvals for its generic versions of digestive disorder drug Nexium and antiviral Valcyte along with days marketing exclusivity stands canceled following a US court decision The DC Federal Court in the US has upheld t...
SPARC gets USFDA nod for its anti-epileptic drug ELEPSIA XR
Wednesday, March 04, 2015Sun Pharma Advanced Research Company has received approval from the US health regulator for its New Drug Application NDA for ELEPSIA XR tablets used for treatment of partial onset seizures in patients with epilepsy The US Food and Drug Administratio...
Sun Pharma to buy Glaxo's opiates business in Australia
Tuesday, March 03, 2015Sun Pharmaceutical Industries Ltd Indias largest drugmaker by sales said on Tuesday it has agreed to buy GlaxoSmithKlines opiates business in Australia to strengthen its pain management portfolio The business consists of analgesics made from raw mat...
